This inventor holds 1 USPTO granted patent. Top assignee: Bioneer Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Sam-Yong Lee in Medical Technology
Introduction
Sam-Yong Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of advanced stent designs. His work focuses on improving patient outcomes through innovative solutions.
Latest Patents
One of Sam-Yong Lee's key patents is for a gold-coated stent, specifically an oligonucleotide bound gold-coated stent, along with the process for producing the same. This invention relates to a gold-plated stent and its preparation method. The stent is coated with various chemical materials such as 2-aminoalkanethiol, epihalogenhydrin, and diamine compounds in a specific sequence. Additionally, the oligonucleotide gold-plated stent is prepared by binding oligonucleotide, a biomaterial, to the gold-plated stent coated with these chemicals. This innovative design aims to raise the local concentration in injured parts while minimizing overall toxicity in the body, making it suitable for preventing restenosis after angioplasty. Sam-Yong Lee holds 1 patent for this invention.
Career Highlights
Sam-Yong Lee is currently associated with Bioneer Corporation, where he continues to work on groundbreaking medical technologies. His expertise and innovative mindset have positioned him as a valuable asset in the field.
Collaborations
He collaborates with talented colleagues, including Jae-Don Lee and Eun-Jung Jung, to further enhance the development of medical devices and technologies.
Conclusion
Sam-Yong Lee's contributions to the field of medical technology, particularly through his innovative gold-coated stent, demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in medical treatments and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
